Episode 3 of The Bean Pod is live!
APOL1-Mediated Kidney Disease in Children
Amirtha Chinnadurai and Jason Misurac join Dr. Laurel Willig to discuss APOL1 disease, emerging therapies, clinical trials, and genetic counseling.
@aspneph.bsky.social
Explore
@aspneph.bsky.social
@robot2trade.bsky.social🧬$VRTX drops positive Phase 2b AMPLIFIED data: inaxaplin cut UACR -42.7% in AMKD w/ modest proteinuria, -17.3% in AMKD+diabetes. Safe & well tolerated. AMPLITUDE pivotal trial now fully enrolled, IA data early 2027 🎯 Truist calls it a positive readthrough for $MAZE's APOL1 program too 👀 #APOL1
